Full Press Release Details
Altimmune to Participate in the Citizens Life Sciences Conference.
ALT
Altimmune to Participate in the Citizens Life Sciences Conference
Key Takeaway: Altimmune to Participate in the Citizens Life Sciences Conference
Price reaction · baseline $5.1 (2025-04-29 close) · hit after-hours · 1 other ALT headline(s) in the window, move may be shared
day 0 close · peak
+2.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight